JPMorgan Starts Amphastar Pharmaceuticals (AMPH) at Overweight, 'Pullback Creates an Attractive Entry Point'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. KLAR
2. KEYS
3. PANW
4. HD
5. DVLT
6. MRNA
7. PGR
8. EPM
9. MRCY
10. LOW

Go back to JPMorgan Starts Amphastar Pharmaceuticals (AMPH) at Overweight, 'Pullback Creates an Attractive Entry Point'

Amphastar Pharmaceuticals (AMPH) PT Lowered to $62 at Jefferies

March 4, 2024 11:04 AM EST

Jefferies analyst Glen Santangelo lowered the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $62.00 (from $66.00) while maintaining a Buy rating.... More